EP Patent

EP3541825B1 — Cyclic phosphate substituted nucleoside derivatives for the treatment of liver diseases

Assigned to Idenix Pharmaceuticals LLC · Expires 2026-04-01 · 0y expired

What this patent protects

Patent listed against pasireotide-pamoate.

Drugs covered by this patent

pasireotide-pamoate (PASIREOTIDE PAMOATE)

Patent Metadata

Patent number: EP3541825B1
Jurisdiction: EP
Classification: —
Expires: 2026-04-01
Drug substance claim: No
Drug product claim: No
Assignee: Idenix Pharmaceuticals LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.